Venture Capital

ICSC's new proptech event aims to bridge the gap between tech founders and CRE leaders, signaling a major industry shift toward large-scale innovation.

Verily Me's AI 'Violet' promises personalized health advice, but a looming lawsuit raises serious questions about data privacy and user trust.

Known for smart vacuums, Dreame is storming the premium phone market with modular cameras, a luxury line, and a bold $1.38 billion R&D gamble.

Shoptalk's 2026 agenda reveals an industry grappling with its AI future, balancing algorithmic power with the essential need for human connection.

Amidst global challenges to open societies, a new online forum from the Institute for Humane Studies aims to defend and redefine liberalism for a new era.

A groundbreaking clinical trial shows a nutrition-based therapy extended life by 34% in stage IV pancreatic cancer patients, offering rare hope.

An Israeli tech firm's new compression technology promises to cut AI data storage by 50% without harming model accuracy, accelerating the future of AVs.

Backed by Goldman Sachs, ORO Labs is using AI orchestration to overhaul how giants like Coca-Cola and Novartis handle spending and compliance.

A $3M government-backed investment is fueling a new model for real estate innovation, merging profit with purpose to tackle housing and climate challenges.

A plant-based gel that stops severe bleeding in seconds is being showcased to top trauma experts, signaling a major shift in emergency medicine.

As AI's energy thirst strains grids, solid-state transformer pioneer DG Matrix hires marketing ace Rainer Stiller to scale its game-changing technology.

Genomic Testing Cooperative opens a Houston lab, leveraging the city's elite oncology ecosystem to expand its unique cooperative model for cancer testing.

Ratio Therapeutics appoints Dr. Colin Hayward as CMO, a strategic move to advance its sarcoma trial and challenge leaders in the booming radiopharmaceutical market.

Ballard Power Systems reports a landmark 2025 with 43% revenue growth, a 37-point margin jump, and its best quarterly cash flow in a decade.

The Tony Elumelu Foundation adds heavyweights from Harvard, IKEA Foundation, and the UAE to its board, signaling a major push for global capital and expertise.

A new clinical trial begins for APAC, a first-in-class drug aiming to prevent amputation and death from severe peripheral artery disease.

With its new $165M fifth fund, StageOne Ventures doubles down on Israel's AI and enterprise tech, reinforcing the nation's resilient innovation ecosystem.

A new catalytic fund aims to bridge Africa's critical early-stage funding gap, turning high-risk green projects into bankable assets for a sustainable future.

Semiconductor leader Melexis launches an autonomous China entity, aiming to dominate the EV and robotics markets by operating at local market velocity.

After a massive divestiture and balance sheet overhaul, Elutia is all-in on its next-gen biomatrix, NXT-41x, to disrupt the $1.5B breast surgery market.